Scalable Generation of Blood Cells and Microglia from hPSCs

The unlimited supply and genetic modifiability of human pluripotent stem cells (hPSCs) make them promising candidates for therapeutic applications. However, scaling protocols to generate large yields of functional hPSC-derived cells for treatment remains a challenge in the field. Standardized protocols such as those developed ��ƽ�� may help researchers to overcome these challenges.

To learn more, join Dr. Leon Lin as he presents a robust and standardized protocol using the STEMdiff™ Hematopoietic Kit to generate over 1 million hPSC-derived hematopoietic progenitor cells (HPCs) per mL in 10 -12 days via monolayer or 3D suspension cultures. These HPCs can be further differentiated into functional myeloid cells to support preclinical development in cell and gene therapy.

Publish Date: July 24, 2025

Request Webinar Form

See other videos & webinars

Webinar: Scalable Generation of Blood Cells and Microglia from hPSCs

To view the webinar, please complete the form, or sign in to your account.

I agree to receive future electronic communications from ��ƽ��. I acknowledge that I can unsubscribe at any time.

By submitting this form, you are providing your consent to ��ƽ�� Technologies Canada Inc. and its subsidiaries and affiliates (“��ƽ��”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.

Request Pricing

Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):

Estimated delivery time for your area

Product sample or exclusive offer

In-lab demonstration

�����ƽ��